Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea

Journal of Clinical Investigation

Volumn 99, Issue 1, 1997, Pages 9-13

  Wills, Peter J ^a   Hall, Roderick L ^b   Chan, Wai Ming ^a,c   Cole, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Bayer plc UK   (United Kingdom)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

expectorants; mucociliary clearance; mucus; osmolar concentration; viscosity

Indexed keywords

EXPECTORANT AGENT; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; BRONCHIECTASIS; BRONCHUS MUCUS; CATTLE; CYSTIC FIBROSIS; DNA DETERMINATION; NONHUMAN; OSMOLALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SALIVA ANALYSIS; SPUTUM EXAMINATION; VISCOELASTICITY;

EID: 0031018453     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119138     Document Type: Article

References (29)

1. Cole, P., and R. Wilson. 1989. Host-microbial interrelationships in respiratory infection. Chest. 95:217S-221S.
2. Wills, P.J., M.J. Garcia Suarez, A. Rutman, R. Wilson, and P.J. Cole. 1995. The ciliary transportability of sputum is slow on the mucus-depleted bovine trachea. Am. J. Respir. Crit. Care Med. 151:1255-1258.
3. Girod, S., J.-M. Zahm, C. Plotkowski, G. Beck, and E. Puchelle. 1992. Role of the physicochemical properties of mucus in the protection of the respiratory epithelium. Eur. Respir. J. 5:477-487.
4. Welsh, M.J., M.P. Anderson, D.P. Rich, L.S. Ostedgaard, R.J. Gregory, S.H. Cheng, and A. Smith. 1993. Cystic fibrosis, CFTR, and abnormal electrolyte transport. In Cystic Fibrosis. P.B. Davis, editor. Marcel Dekker, New York. 29-52.
5. Knowles, M.R., N.L. Church, W.E. Waltner, J.R. Yankaskas, P. Gilligan, M. King, L.J. Edwards, R.W. Helms, and R.C. Boucher. 1990. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 322:1189-1194.
6. Verdugo, P. 1995. Molecular biophysics of mucin secretion. In Airway Secretion. T. Takishima and S. Shimura, editors. Marcel Dekker, New York. 101-121.
7. Matthews, L.W., S. Spector, J. Lemm, and J.L. Potter. 1963. Studies on pulmonary secretions. I. The over-all chemical composition of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am. Rev. Respir. Dis. 88:199-204.
8. Potter, J.L., L.W. Matthews, S. Spector, and J. Lemm. 1967. Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis. bronchiectasis, and laryngectomy. Am. Rev. Respir. Dis. 96:83-87.
9. Tomkiewicz, R.P., E.M. App, J.G. Zayas, O. Ramirez, N. Church, R.C. Boucher, M.R. Knowles, and M. King. 1993. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum. Am. Rev. Respir. Dis. 148:1002-1007.
10. Quinton, P.M. 1994. Viscosity versus composition in airway pathology. Am. J. Respir. Crit. Care Med. 149:6-7.
11. + transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest. 78:1245-1252.
12. Wills, P.J., and P.J. Cole. 1994. Hypertonic saline increases the ciliary transportability of bronchiectatic sputum. Am. J. Respir. Crit. Care Med. 149: A119. (Abstr.)
13. Rutland, J., and P.J. Cole. 1980. Non-invasive sampling of nasal cilia for measurement of beat frequency and study of ultrastructure. Lancet. ii:564-565.
14. Harding, S.E., and M. Creeth. 1983. Polyelectrolyte behaviour in mucus glycoproteins. Biochem. Biophys. Acta. 746:114-119.
15. Luk, C.K.A., and M.J. Dulfano. 1983. Effect of pH, viscosity and ionic-strength changes on ciliary beating frequency of human bronchial explants. Clin. Sci. 64:449-451.
16. Joris, L., I. Dab, and P.M. Quinton. 1993. Elemental composition of human airway surface fluid in healthy and diseased airways. Am. Rev. Respir. Dis. 148:1633-1637.
17. Mizgerd, J.P., L. Kobzik, A.E. Warner, and J.D. Brain. 1995. Effects of sodium concentration on human neutrophil bactericidal functions. Am. J. Physiol. 269:L388-L393.
18. Smith, J.J., S.M. Travis, E.P. Greenberg, and M.J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 85:229-236.
19. Boucher, R.C. 1994. Human airway ion transport. Part two. Am. J. Respir. Crit. Care Med. 150:581-593.
20. Widdicombe, J.G. 1994. Force of capillarity tending to prevent drying of ciliary mucosa. In Cystic Fibrosis - Current Topics, Volume 2. J.A. Dodge, D.J.H. Brock, and J.H. Widdicombe, editors. Wiley, Chichester. 597.
21. Kollberg, H., B. Mossberg, B.A. Afzelius, K. Philipson, and P. Camner. 1978. Cystic fibrosis compared with the immotile-cilia syndrome. Scand. J. Respir. Dis. 59:297-306.
22. Noone, P.G., W.D. Bennett, K.L. Zeman, J.A. Regnis, J.L. Carson, R.C. Boucher, and M.R. Knowles. 1996. Effects on cough clearance of aerosolized uridine-5′-triphosphate±amiloride in patients with primary ciliary dyskinesia. Am. J. Respir. Crit. Care Med. 153:A530. (Abstr.)
23. Pavia, D., M.L. Thomson, and S.W. Clarke. 1978. Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am. Rev. Respir. Dis. 117:199-203.
24. Robinson, M., J.A. Regnis, D.L. Bailey, M. King, G.J. Bautovich, and P.T.P. Bye. 1996. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 153: 1503-1509.
25. Daviskas, E., S.D. Anderson, I. Gonda, S. Eberi, S. Meikle, J.P. Seale, and G. Bautovich. 1996. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur. Respir. J. 9:725-732.
26. Eng, P.A., J. Morton, J.A. Douglass, J. Riedler, J. Wilson, and C.F. Robertson. 1996. Short-term efficacy of ultrasonically nebulised hypertonic saline in cystic fibrosis. Pediatr. Pulmonol. 21:77-83.
27. App, E.M., M. King, R. Helfesrieder, D. Köhler, and H. Matthys. 1990. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. Am. Rev. Respir. Dis. 141:605-612.
28. Graham, A., A. Hasani, E.W.F.W. Alton, G.P. Martin, C. Marriott, M.E. Hodson, S.W. Clarke, and D.M. Geddes. 1993. No added benefit from nebulised amiloride in patients with cystic fibrosis. Eur. Respir. J. 6:1243-1248.
29. Bennett, W.D., K.N. Olivier, K.L. Zeman, K.N. Hohneker, R.C. Boucher, and M.R. Knowles. 1996. The effect of uridine 5′-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am. J. Respir. Crit. Care Med. 153:1796-1801.